Therapies frequently used in psoriasis patients such as dimethylfumarate or apremilast can inhibit chemokines like Cxcl9 and Cxcl10, which highlights the role of these two chemokines in psoriasis [45,46]. This evidence concerns the gene CXCL10 and psoriasis.